Literature DB >> 16205870

[Treatment and prophylaxis of recurrent urinary tract infections].

B Banas1, B K Krämer.   

Abstract

Recurrent urinary tract infections are typical diseases of sexually active young women. Only elder women show significant rates of underlying, mostly urological diseases. Besides behavioral changes long-term antimicrobial therapy is still the mainstay of both prophylaxis and therapy. This report provides information on the etiology for recurrent urinary tract infections. Strategies for prevention are illustrated. The actual significances of organic remedies and antibiotics respectively are discussed; ineffective therapies are identified. Furthermore an outlook is given on promising novel therapeutics, i.e. vaccines which are already tested in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16205870     DOI: 10.1007/s00108-005-1514-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

1.  Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis.

Authors:  Xin Li; Jarrod L Erbe; C Virginia Lockatell; David E Johnson; Michael G Jobling; Randall K Holmes; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  Risk factors for second urinary tract infection among college women.

Authors:  B Foxman; B Gillespie; J Koopman; L Zhang; K Palin; P Tallman; J V Marsh; S Spear; J D Sobel; M J Marty; C F Marrs
Journal:  Am J Epidemiol       Date:  2000-06-15       Impact factor: 4.897

Review 3.  Diagnosis and management of pediatric urinary tract infections.

Authors:  Joseph J Zorc; Darcie A Kiddoo; Kathy N Shaw
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Analysis and bioactive evaluation of the compounds absorbed into blood after oral administration of the extracts of Vaccinium vitis-idaea in rat.

Authors:  Xijun Wang; Hui Sun; Yuling Fan; Lijing Li; Toshiaki Makino; Yoshihiro Kano
Journal:  Biol Pharm Bull       Date:  2005-06       Impact factor: 2.233

Review 5.  Prostatitis and urinary tract infection in men: what's new; what's true?

Authors:  B A Lipsky
Journal:  Am J Med       Date:  1999-03       Impact factor: 4.965

6.  Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.

Authors:  S Langermann; R Möllby; J E Burlein; S R Palaszynski; C G Auguste; A DeFusco; R Strouse; M A Schenerman; S J Hultgren; J S Pinkner; J Winberg; L Guldevall; M Söderhäll; K Ishikawa; S Normark; S Koenig
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

7.  A prospective study of risk factors for symptomatic urinary tract infection in young women.

Authors:  T M Hooton; D Scholes; J P Hughes; C Winter; P L Roberts; A E Stapleton; A Stergachis; W E Stamm
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

8.  Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women.

Authors:  R Ikäheimo; A Siitonen; T Heiskanen; U Kärkkäinen; P Kuosmanen; P Lipponen; P H Mäkelä
Journal:  Clin Infect Dis       Date:  1996-01       Impact factor: 9.079

Review 9.  Minireview: functions of the renal tract epithelium in coordinating the innate immune response to infection.

Authors:  Paramit Chowdhury; Steven H Sacks; Neil S Sheerin
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

10.  A reassessment of the importance of "low-count" bacteriuria in young women with acute urinary symptoms.

Authors:  C M Kunin; L V White; T H Hua
Journal:  Ann Intern Med       Date:  1993-09-15       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.